Pre-clinical Study Results: Multipotent Adult Progenitor Cells on an Allograft Scaffold
Pre-clinical studies suggest that multipotent adult progenitor cells (MAPCs), such as the technology used in RTI Surgical’s map3® Cellular Allogeneic Bone Grafts, exhibited a more robust angiogenic protein release profile vs. mesenchymal stem cells in vitro. Jul 26, 2016